Chief Medical Officer
This is a career defining opportunity where you will play a key role in the vision and strategy of a dynamic Biotechnology Company bringing novel immunotherapy drugs into development to benefit cancer patients.
Entries by
Vice President Business Development Integrated Discovery & Development, USA
Our client is a knowledge-based, science-led business providing a wide range of innovative and integrated solutions to clients in the pharmaceutical, biotechnology, food, environmental, agrochemical, petrochemical, chemical and consumer products sectors; a business that has enjoyed tremendous success, providing integrated, high quality drug discovery, development and analytical services to the life science sector.
Senior Director / Vice President Business Development, EMEA
Our client is a global leader, providing clinical services of the highest quality to Pharma, Biotech, Life Science and CRO businesses; a business that has enjoyed significant and consistent growth and outstanding success. This has been driven by the successful delivery of clinical trials of the highest standards, through their people, unique business model and service offering, global reach and transparency.
Senior Director / Vice President Advisory Services UK/EU
An outstanding opportunity to join a highly successful, ambitious and growing Life Science Consultancy, dedicated to the provision of high quality advisory and consulting services within Pharma R&D through their industry expertise and knowledge.
Vice President Early Development Services
Our client is a leading global CRO, a company that has enjoyed significant and consistent growth and success. They have an outstanding reputation for delivery of all aspects of full service delivery including significant investment in the development of state-of-the-art Early Development Service facilities in Europe and North America. Their European Phase I units are newly refurbished and purpose built, providing outstanding technology, facilities, services and safety.
Executive Director, Health Economics and Outcomes Research (HEOR), EU / USA
As Executive Director, HEOR you will play a key role in building an outstanding HEOR business and capability through internal resources and seeking external partnerships, within the Late Phase business unit. You will bring a high level of credibility with the ability to work closely with customers, and help to create a vision for a world leading HEOR business as an HEOR Subject Matter Expert. You will be expected to provide scientific, business development and commercial expertise, defining new service offerings that will create a competitive advantage, to include HEOR Consulting services.
Vice President, Subject Matter Expert, Late Phase
As Vice President, SME Late Phase you will bring deep knowledge and expertise across all aspects of Late Phase development. You will bring a high level of credibility with the ability to work closely with customers, and help to create a vision for a world leading Late Phase business. You will be expected to provide scientific and commercial expertise, defining new service offerings that will create a competitive advantage.
Executive Vice President Operations, Europe & Asia Pacific
As Executive Vice President Operations you will be expected to provide vision, leadership and overall operationally responsibility for the highly successful operations group across Europe, Asia Pacific and Africa. You will be responsible for the further growth of existing groups and the continued development of new markets and businesses. This will include organic growth as well as significant input into Mergers & Acquisitions and Joint Ventures internationally.
Head of Transgene Delivery
The Head of Transgene Delivery will be accountable for building and leading a team of expert scientists responsible for optimising and expressing transgenes within a range of viral and non-viral vectors for optimal delivery.
Head of Transgene Discovery
The Head of Transgene Discovery will be responsible for developing and leading a team in the design, generation and optimisation of therapeutic proteins, including antibody fragments, tool reagents, and recombinant proteins. There will be particular emphasis on the development of these proteins to be expressed within recombinant lentivirus and adeno-associated virus to support pre-clinical projects.